Core Insights - Medline's shares surged 41% in their trading debut, closing at $41 after raising $6.26 billion in its IPO, marking one of the largest IPOs in recent years [1][4][7] Group 1: IPO Details - Medline sold over 216 million shares at $29 each, at the higher end of its anticipated range of $26 to $30 [2] - The proceeds from the IPO will be used to pay down some of the company's debts [2] Group 2: Financial Performance - For the first nine months of the year ending in September, Medline reported a net income of $977 million on revenue of $20.65 billion, an increase from $911 million on $18.72 billion in the same period the previous year [3] Group 3: Market Context - The IPO marks a recovery in the IPO market, although activity remains below the record levels seen in 2021 [4] - The $6.26 billion raised makes it the largest IPO since Rivian's $11.93 billion in 2021 [4] Group 4: Company Vision - CEO Jim Boyle stated that the IPO is expected to enhance Medline's brand, aiming to position the company as the "Costco of healthcare" for medical equipment buyers [5]
Medical Supply Firm Medline's Stock Jumps 41% in Its Trading Debut